Zacks Research Brokers Decrease Earnings Estimates for THC

Tenet Healthcare Co. (NYSE:THCFree Report) – Stock analysts at Zacks Research reduced their Q1 2026 earnings estimates for Tenet Healthcare in a research report issued on Wednesday, March 26th. Zacks Research analyst R. Department now forecasts that the company will post earnings of $3.43 per share for the quarter, down from their prior forecast of $3.45. The consensus estimate for Tenet Healthcare’s current full-year earnings is $12.24 per share. Zacks Research also issued estimates for Tenet Healthcare’s Q4 2026 earnings at $3.56 EPS and FY2026 earnings at $13.40 EPS.

A number of other research firms have also recently weighed in on THC. StockNews.com raised Tenet Healthcare from a “hold” rating to a “buy” rating in a report on Thursday, March 13th. Barclays decreased their target price on Tenet Healthcare from $190.00 to $161.00 and set an “overweight” rating on the stock in a research report on Thursday, February 13th. KeyCorp cut their price target on shares of Tenet Healthcare from $200.00 to $185.00 and set an “overweight” rating for the company in a report on Tuesday, January 7th. Morgan Stanley initiated coverage on shares of Tenet Healthcare in a research report on Wednesday. They issued an “overweight” rating and a $165.00 target price on the stock. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $177.00 price target on shares of Tenet Healthcare in a research report on Thursday, February 13th. Three investment analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $166.41.

View Our Latest Research Report on THC

Tenet Healthcare Trading Down 0.9 %

Shares of Tenet Healthcare stock opened at $133.17 on Friday. Tenet Healthcare has a fifty-two week low of $90.03 and a fifty-two week high of $171.20. The company has a debt-to-equity ratio of 2.25, a quick ratio of 1.70 and a current ratio of 1.78. The company has a market cap of $12.67 billion, a P/E ratio of 4.13, a price-to-earnings-growth ratio of 1.02 and a beta of 2.06. The firm has a 50-day simple moving average of $132.43 and a two-hundred day simple moving average of $142.50.

Tenet Healthcare (NYSE:THCGet Free Report) last posted its earnings results on Wednesday, February 12th. The company reported $3.44 earnings per share for the quarter, beating the consensus estimate of $2.95 by $0.49. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%.

Institutional Trading of Tenet Healthcare

Hedge funds have recently made changes to their positions in the business. New Wave Wealth Advisors LLC purchased a new position in Tenet Healthcare in the 4th quarter valued at approximately $343,000. Swedbank AB grew its stake in Tenet Healthcare by 100.0% during the 4th quarter. Swedbank AB now owns 40,000 shares of the company’s stock worth $5,049,000 after purchasing an additional 20,000 shares in the last quarter. Signet Financial Management LLC acquired a new stake in Tenet Healthcare in the 4th quarter valued at about $1,526,000. China Universal Asset Management Co. Ltd. purchased a new stake in shares of Tenet Healthcare during the fourth quarter worth approximately $410,000. Finally, C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new position in Tenet Healthcare in the fourth quarter worth approximately $5,892,000. Institutional investors and hedge funds own 95.44% of the company’s stock.

Insider Buying and Selling

In related news, Director J Robert Kerrey sold 9,525 shares of the firm’s stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $125.43, for a total transaction of $1,194,720.75. Following the completion of the sale, the director now directly owns 27,378 shares in the company, valued at approximately $3,434,022.54. This trade represents a 25.81 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.93% of the stock is currently owned by company insiders.

About Tenet Healthcare

(Get Free Report)

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

See Also

Earnings History and Estimates for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.